Miss Gill Cann
- Affiliate (School of Chemistry)
email:
Gillian.Cann@glasgow.ac.uk
Keltic Pharma Therapeutics, The ARC, University of Glasgow, Glasgow, G11 6EW
Publications
2025
Brettell, Skye B., Cann, Gillian, Begen, Abbey, Sharma, Saumya, Mahindra, Amit, Carruthers, Lauren V. 
ORCID: https://orcid.org/0000-0003-4346-2283, Milligan, Graeme ORCID: https://orcid.org/0000-0002-6946-3519, Clarke, David J., Tobin, Andrew B. ORCID: https://orcid.org/0000-0002-1807-3123 and Jamieson, Andrew G. ORCID: https://orcid.org/0000-0003-1726-7353
(2025)
Lysine targeting covalent inhibitors of malarial kinase PfCLK3.
RSC Medicinal Chemistry,
(Accepted for Publication)
Articles
Brettell, Skye B., Cann, Gillian, Begen, Abbey, Sharma, Saumya, Mahindra, Amit, Carruthers, Lauren V. ORCID: https://orcid.org/0000-0003-4346-2283, Milligan, Graeme ORCID: https://orcid.org/0000-0002-6946-3519, Clarke, David J., Tobin, Andrew B. ORCID: https://orcid.org/0000-0002-1807-3123 and Jamieson, Andrew G. ORCID: https://orcid.org/0000-0003-1726-7353
(2025)
Lysine targeting covalent inhibitors of malarial kinase PfCLK3.
RSC Medicinal Chemistry,
(Accepted for Publication)